Multiplex Assay Kit for Neuropeptide Y (NPY) ,etc. by CBA (Cytometric Bead Array)

NP-Y; PYY4; CPON; Pro-neuropeptide Y; Neuropeptide tyrosine; C-flanking peptide of NPY

Specificity

This assay has high sensitivity and excellent specificity for detection of Neuropeptide Y (NPY) ,etc. by CBA (Cytometric Bead Array).
No significant cross-reactivity or interference between Neuropeptide Y (NPY) ,etc. by CBA (Cytometric Bead Array) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Neuropeptide Y (NPY) ,etc. by CBA (Cytometric Bead Array) and the recovery rates were calculated by comparing the measured value to the expected amount of Neuropeptide Y (NPY) ,etc. by CBA (Cytometric Bead Array) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 80-102 84
EDTA plasma(n=5) 96-104 99
heparin plasma(n=5) 95-102 98

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Neuropeptide Y (NPY) ,etc. by CBA (Cytometric Bead Array) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Neuropeptide Y (NPY) ,etc. by CBA (Cytometric Bead Array) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Neuropeptide Y (NPY) ,etc. by CBA (Cytometric Bead Array) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 90-101% 89-101% 80-98% 91-99%
EDTA plasma(n=5) 97-105% 86-97% 99-105% 92-99%
heparin plasma(n=5) 80-105% 90-102% 83-93% 78-99%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:NPY) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Add 200μL analysis buffer solution to each well of the plate for pre-wetting;
2. Preparation of standards, reagents and samples before the experiment;
3. Add 50μL standard or sample to each well, add 50μL prepared Detection Reagent A, add 10μL magnetic beads, and incubate 90 minutes protect from light at 25°C on shaker;
4. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent B, and incubate 30 minutes protect from light at 25°C on shaker;
5. Wash plate once on magnetic frame;
6. Add 100μL sheath fluid, swirl for 10 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Hemodialysis International Is there any interaction of resistin and adiponectin levels with protein‐energy wasting among patients with chronic kidney disease Onlinelibrary: hdi.12072
Journal of Pediatric Endocrinology and Metabolism Changes in growth pattern, leptin ghrelin and neuropeptide Y levels after adenotonsillectomy in prepubertal children Degruyter: Source
Ren Fail. The role of adipocytokines on depressive symptoms of patients with chronic kidney disease Pubmed: 23879728
Coronary Artery Disease The relationship of plasma neuropeptide Y levels with coronary collateral development. Pubmed: 24077326
Coronary Artery Disease The relationship of plasma neuropeptide Y levels with coronary collateral development Lww:Source
Toxicology Letters Possible role of serotonin and neuropeptide Y on the disruption of the reproductive axis activity by perfluorooctane sulfonate Pubmed:25623392
J Neurosurg Anesthesiol High Plasma Levels of Neuropeptide Y Correlate With Good Clinical Outcome But are not Correlated to Cerebral Blood Flow or Vasospasm After Subarachnoid Hemorrhage PubMed: 25955865
Journal of Diabetes Research High Intensity Aerobic Exercise Training Improves Deficits of Cardiovascular Autonomic Function in a Rat Model of Type 1 Diabetes Mellitus with Moderate … Pubmed:26885531
Archives of Gynecology and Obstetrics Binge eating and biochemical markers of appetite in new users of the contraceptive depot medroxyprogesterone acetate pubmed:27604241
basic & clinical pharmacology & toxicology Effects of Di-isononyl Phthalate on Neuropeptide Y Expression in Differentiating Human Neuronal Cells. pubmed:27625336
Acta Neurobiologiae Experimentalis Aberrant changes of somatostatin and neuropeptide Y in brain of a genetic rat model for epilepsy: tremor rat pubmed:27685769
Cardiovascular research Nur77 protects against adverse cardiac remodelling by limiting Neuropeptide Y signalling in the sympathoadrenal-cardiac axis Pubmed:29850786
Journal of Periodontology Salivary neuropeptides, stress, and periodontitis Pubmed:28914594
Neuropeptides Mechanisms of sustained long-term weight loss after RYGB: α-MSH is a key factor Pubmed:29685637
Pharmacology Melatonin Induces Osteoblastic Differentiation of Mesenchymal Stem Cells and Promotes Fracture Healing in a Rat Model of Femoral Fracture via Neuropeptide Y … Pubmed: 30227410
Marmara Medical Journal Investigation of the relationship between insulin resistance and neuropeptide Y levels in polycystic ovary syndrome
Marmara Medical Journal Investigation of the relationship between insulin resistance and neuropeptide Y levels in polycystic ovary syndrome.
neurochemical research Sevoflurane Induces Hippocampal Neuronal Apoptosis by Altering the Level of Neuropeptide Y in Neonatal Rats. Pubmed: 32378074
Hum Psychopharmacol Serum levels of neuropeptide Y in patients with chronic schizophrenia during treatment augmentation with sarcosine (results of the double©\blind randomized?¡­ 33245168
Arch Toxicol Serotonin involvement in okadaic acid-induced diarrhoea in vivo 34148100
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPA879Hu01 Recombinant Neuropeptide Y (NPY) Positive Control; Immunogen; SDS-PAGE; WB.
CPA879Hu22 OVA Conjugated Neuropeptide Y (NPY) Immunogen; SDS-PAGE; WB.
CPA879Hu21 OVA Conjugated Neuropeptide Y (NPY) Immunogen; SDS-PAGE; WB.
PAA879Hu08 Polyclonal Antibody to Neuropeptide Y (NPY) WB; IHC; ICC; IP.
PAA879Hu01 Polyclonal Antibody to Neuropeptide Y (NPY) WB,IHC,ICC/IF
LAA879Hu71 Biotin-Linked Polyclonal Antibody to Neuropeptide Y (NPY) WB; IHC; ICC.
MAA879Hu22 Monoclonal Antibody to Neuropeptide Y (NPY) Testing in progress
MEA879Hu Mini Samples ELISA Kit for Neuropeptide Y (NPY) Enzyme-linked immunosorbent assay for Antigen Detection.
CEA879Hu ELISA Kit for Neuropeptide Y (NPY) Enzyme-linked immunosorbent assay for Antigen Detection.
LMA879Hu Multiplex Assay Kit for Neuropeptide Y (NPY) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
CMA879Hu Multiplex Assay Kit for Neuropeptide Y (NPY) ,etc. by CBA (Cytometric Bead Array) FLIA Kit for Antigen Detection.
KSA879Hu11 ELISA Kit DIY Materials for Neuropeptide Y (NPY) Main materials for "Do It (ELISA Kit) Yourself".